Drug Channels

JANUARY 5, 2021

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 5, 2021

Edward discusses the impact of providing access to drug price transparency and affordability programs to healthcare providers and patients at the point of care. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. To learn more about AssistRx’s solutions, visit AssistRx.com.

Drug Pricing 52

Drug Pricing 52

Drug Channels

JUNE 22, 2022

See The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards. In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. d/b/a Drug Channels Institute.

Drug Pricing 76

Drug Pricing 76

Drug Channels

FEBRUARY 7, 2024

And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.

Drug Pricing 93

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 93

Drug Channels

MARCH 23, 2021

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 21, 2024

How will the most consequential change in federal drug pricing policy affect drug pricing? Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Drug Pricing 98

Drug Pricing 98

Drug Channels

AUGUST 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.

Drug Pricing 72

Drug Pricing Hospitals 72

Drug Channels

MARCH 25, 2021

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. When Americans complain about “drug prices,” most are actually complaining about the share of costs they pay—and how those costs are computed. drug channel.

Drug Pricing 52

Drug Pricing 52

pharmaphorum

JULY 29, 2021

The company took advantage of the lack of generic competitors on the market to charge the NHS “excessive and unfair prices” for liothyronine, which meant that NHS spending on the drug swelled from £600,000 in 2006 to more than £30 million by 2016.

Drug Pricing 98

Drug Pricing 98

Drug Channels

DECEMBER 8, 2020

When Americans complains about “drug prices,” most are actually complaining about the share of costs they pay—and how those costs are computed. drug channel. Today, I review four crucial issues that the new Congress could tackle to address affordability, patients' out-of-pocket obligations, and prescription prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. How will the most consequential change in federal drug pricing policy affect the largest pharmacies and PBMs? Pharmacies and Pharmacy Benefit Managers. to 1:30 p.m.

Drug Pricing 81

Drug Pricing 81

Drug Channels

APRIL 1, 2024

Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Drug Pricing 87

Drug Pricing Hospitals 87

Drug Channels

OCTOBER 12, 2020

Informa Connect-CBI’s 6th Edition Drug Pricing Transparency Congress. November 16-17, 2020 | Virtual Event www.informaconnect.com/drug-pricing-transparency. Drug Channels Readers: View the complete agenda and register today. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Drug Pricing 40

Drug Pricing 40

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 56

Drug Pricing Hospitals Biosimilars 56

Drug Channels

SEPTEMBER 30, 2020

We’ve been squirrelling away these acorns from the mighty Drug Channels oaks: I agree. Brand-name drugs prices keep on dropping It’s official: CVS Health’s Zinc GPO actually exists! Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Autumn is here! You can also join my 23.3K

Drug Pricing 52

Drug Pricing 52

Drug Channels

OCTOBER 4, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs at the biggest drugmakers to less than half of their list prices.

Drug Pricing 87

Drug Pricing Pharmaceutical Manufacturing 87

Drug Channels

MAY 10, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs to less than half of their list prices. That’s why I refer to them as drug pricing flat earthers (#DPFE).

Drug Pricing 91

Drug Pricing Pharmaceutical Manufacturing 91

Drug Channels

SEPTEMBER 29, 2023

According to Kalderos, at least 5% of commercial rebates are paid for prescriptions that also have discounts under the 340B Drug Pricing Program. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Drug Pricing 82

Drug Pricing 82

Drug Channels

DECEMBER 15, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 Every 340B covered entity type experienced double-digit growth, despite drug prices that grew more slowly than overall inflation.

Drug Pricing 82

Drug Pricing Hospitals 82

Drug Channels

MARCH 18, 2024

Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered! All rights reserved.

Drug Pricing 78

Drug Pricing 78

Drug Channels

JUNE 14, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. As Nobel prize winner Ronald Coase observed: “If you torture the data long enough, it will confess to anything.” Read on and consider what the data are really saying.

Drug Pricing 81

Drug Pricing 81

Drug Channels

JULY 28, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs to less than half of their list prices. That’s why I refer to them as drug pricing flat earthers (#DPFE).

Drug Pricing 90

Drug Pricing Pharmaceutical Manufacturing 90

Drug Channels

APRIL 27, 2021

drug pricing policy. Recent posts have covered biosimilars, pharmacist workloads, formularies, pricing, PSAOs, Part D spending, copay accumulators, H.R.3, Recent posts have covered biosimilars, pharmacist workloads, formularies, pricing, PSAOs, Part D spending, copay accumulators, H.R.3, d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Biosimilars 52

Drug Channels

JUNE 1, 2023

Vishali discusses the persistent challenges of duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. To learn more, sign up now for priority access to Kalderos’ 2023 annual report: Mission Critical: Bringing Drug Discount Stakeholders Together so Patients Win.

Drug Pricing 75

Drug Pricing 75

Drug Channels

SEPTEMBER 24, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 The difference between list prices and discounted 340B purchases also grew, to $52.3 d/b/a Drug Channels Institute. billion (+$2.6

Drug Pricing 71

Drug Pricing Hospitals 71

Drug Channels

AUGUST 22, 2023

ICYMI: A Big Health Insurer Is Ripping Up the Playbook on Drug Pricing I commend Blue Shield of California for undertaking a noble experiment to unbundle the PBM business model. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.

Drug Pricing 95

Drug Pricing 95

Drug Channels

APRIL 18, 2023

Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program. The IRA will alter many crucial aspects of the Medicare program and the overall drug channel. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 87

Drug Pricing 87

Drug Channels

MARCH 7, 2024

On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription drug channels. Special preorder and launch pricing discounts will be valid through April 7, 2024. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Drug Pricing 79

Drug Pricing 79

Drug Channels

JUNE 13, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs at the biggest drugmakers to less than half of their list prices.

Drug Pricing 81

Drug Pricing Pharmaceutical Manufacturing 81

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. Read on for full details on pricing and registration. All rights reserved.

Drug Pricing 85

Drug Pricing Biosimilars 85

Drug Channels

JUNE 20, 2023

Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program. The IRA will alter many crucial aspects of the Medicare program and the overall drug channel. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 84

Drug Pricing 84

Drug Channels

MARCH 19, 2024

drug pricing, reimbursement, and dispensing system. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The 2024 Economic Report on U.S. This 2024 edition includes substantial new material—outlined on page ix of the report overview. Read on for some additional details.

Drug Pricing 72

Drug Pricing 72

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Drug Pricing 76

Drug Pricing 76

Drug Channels

NOVEMBER 8, 2022

drug channel, the roles and controversies around pharmacy benefit managers (PBMs), GoodRx, Mark Cuban’s cost-plus pharmacy, the 340B Drug Pricing Program, and much more. P.S. Let me know if you’d like to see more audio/podcast content on Drug Channels. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Drug Pricing 81

Drug Pricing 81

Drug Channels

JULY 18, 2023

Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies. These shortcomings, combined with physician hesitancy, will limit the ability of price to drive adoption. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Biosimilars 78

Biosimilars Drug Pricing 78

Drug Channels

JULY 5, 2022

Read on for full details on pricing and registration. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.

Drug Pricing 85

Drug Pricing 85

Drug Channels

AUGUST 15, 2022

Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. The data tell a familiar story.

Hospitals 92

Hospitals Drug Pricing 92